Interim results of the JULIET trial of CTL019 in R/R DLBCL
EBMT Debate Session | How to treat R/R DLBCL in 2019? | Part 3 – CAR-T
A Keynote Debate Session on how to treat patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) took...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month